nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network
|
Liang, Ying |
|
|
83 |
C |
p. 596-604 |
artikel |
2 |
Anticancer properties of chimeric HDAC and kinase inhibitors
|
Biersack, Bernhard |
|
|
83 |
C |
p. 472-486 |
artikel |
3 |
Cancer epigenetics: Past, present and future
|
Lee, Jae Eun |
|
|
83 |
C |
p. 4-14 |
artikel |
4 |
Causes, effects, and clinical implications of perturbed patterns within the cancer epigenome
|
Oleksiewicz, Urszula |
|
|
83 |
C |
p. 15-35 |
artikel |
5 |
Circular RNAs as biomarkers and therapeutic targets in cancer
|
Beilerli, Aferin |
|
|
83 |
C |
p. 242-252 |
artikel |
6 |
Coordinated methyl readers: Functional communications in cancer
|
Park, Il-Geun |
|
|
83 |
C |
p. 88-99 |
artikel |
7 |
CRISPR/Cas mediated epigenome editing for cancer therapy
|
Ansari, Imran |
|
|
83 |
C |
p. 570-583 |
artikel |
8 |
Current and emerging molecular and epigenetic disease entities in acute myeloid leukemia and a critical assessment of their therapeutic modalities
|
Zhao, Xin |
|
|
83 |
C |
p. 121-135 |
artikel |
9 |
Current paradigms in epigenetic anticancer therapeutics and future challenges
|
Singh, Manoj |
|
|
83 |
C |
p. 422-440 |
artikel |
10 |
Dietary isothiocyanates inhibit cancer progression by modulation of epigenome
|
Sundaram, Madhumitha Kedhari |
|
|
83 |
C |
p. 353-376 |
artikel |
11 |
Dietary molecules and experimental evidence of epigenetic influence in cancer chemoprevention: An insight
|
Ullah, Mohammad Fahad |
|
|
83 |
C |
p. 319-334 |
artikel |
12 |
Editorial Board
|
|
|
|
83 |
C |
p. ii |
artikel |
13 |
Effect of non-enzymatic glycosylation in the epigenetics of cancer
|
Rehman, Shahnawaz |
|
|
83 |
C |
p. 543-555 |
artikel |
14 |
Emerging noninvasive methylation biomarkers of cancer prognosis and drug response prediction
|
Oliver, Javier |
|
|
83 |
C |
p. 584-595 |
artikel |
15 |
Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer
|
Xie, Wangkai |
|
|
83 |
C |
p. 303-318 |
artikel |
16 |
Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
|
Sher, Gulab |
|
|
83 |
C |
p. 152-165 |
artikel |
17 |
Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs
|
Farooqi, Ammad Ahmad |
|
|
83 |
C |
p. 197-207 |
artikel |
18 |
Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease
|
Khan, Parvez |
|
|
83 |
C |
p. 57-76 |
artikel |
19 |
Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance
|
Fatma, Homa |
|
|
83 |
C |
p. 166-176 |
artikel |
20 |
Epigenetic regulation in the pathogenesis of non-melanoma skin cancer
|
Kashyap, Mahendra Pratap |
|
|
83 |
C |
p. 36-56 |
artikel |
21 |
Epigenetic Regulation of Cancer Immune Cells
|
Avella Patino, Diego M. |
|
|
83 |
C |
p. 377-383 |
artikel |
22 |
Epigenetic Regulation of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway
|
Akhtar, Sabah |
|
|
83 |
C |
p. 177-196 |
artikel |
23 |
Epigenetic regulation of papillary thyroid carcinoma by long non-coding RNAs
|
Lin, Rui-Xin |
|
|
83 |
C |
p. 253-260 |
artikel |
24 |
Epigenetic regulation of RNA sensors: Sentinels of immune response
|
Khan, Mohammad Imran |
|
|
83 |
C |
p. 413-421 |
artikel |
25 |
Epigenetic reprogramming during prostate cancer progression: A perspective from development
|
Goel, Sakshi |
|
|
83 |
C |
p. 136-151 |
artikel |
26 |
Epigenetic signature associated with thyroid cancer progression and metastasis
|
Zhang, Hong |
|
|
83 |
C |
p. 261-268 |
artikel |
27 |
Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches
|
Uddin, Md. Sahab |
|
|
83 |
C |
p. 100-120 |
artikel |
28 |
Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19
|
Ahmad, Shama |
|
|
83 |
C |
p. 384-398 |
artikel |
29 |
Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress
|
Neganova, Margarita E. |
|
|
83 |
C |
p. 452-471 |
artikel |
30 |
Inflammasomes in cancer: Effect of epigenetic and autophagic modulations
|
Mishra, Soumya Ranjan |
|
|
83 |
C |
p. 399-412 |
artikel |
31 |
Long non-coding RNAs as epigenetic mediator and predictor of glioma progression, invasiveness, and prognosis
|
Zhang, Yang |
|
|
83 |
C |
p. 536-542 |
artikel |
32 |
miRNAs mediated drug resistance in hematological malignancies
|
Peixoto da Silva, Sara |
|
|
83 |
C |
p. 283-302 |
artikel |
33 |
Mitochondrial mutations and mitoepigenetics: Focus on regulation of oxidative stress-induced responses in breast cancers
|
Chen, Kuo |
|
|
83 |
C |
p. 556-569 |
artikel |
34 |
Nutrition and upper gastrointestinal cancers: An overview of current understandings
|
Kayamba, Violet |
|
|
83 |
C |
p. 605-616 |
artikel |
35 |
Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update
|
Mondal, Priya |
|
|
83 |
C |
p. 503-522 |
artikel |
36 |
Regulatory effects of noncoding RNAs on the interplay of oxidative stress and autophagy in cancer malignancy and therapy
|
Liu, Pei-Feng |
|
|
83 |
C |
p. 269-282 |
artikel |
37 |
Role of epigenetics in carcinogenesis: Recent advancements in anticancer therapy
|
Hussain, Showket |
|
|
83 |
C |
p. 441-451 |
artikel |
38 |
Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseases
|
Khan, Abdul Q. |
|
|
83 |
C |
p. 208-226 |
artikel |
39 |
Special Issue: Epigenetic regulation of cancer progression: Promises and progress
|
Ahmad, Aamir |
|
|
83 |
C |
p. 1-3 |
artikel |
40 |
Targeting DNA methyltransferases in non-small-cell lung cancer
|
Al-Yozbaki, Minnatallah |
|
|
83 |
C |
p. 77-87 |
artikel |
41 |
Targeting epigenetic regulatory machinery to overcome cancer therapy resistance
|
Guo, Lei |
|
|
83 |
C |
p. 487-502 |
artikel |
42 |
The emerging role of non-coding RNAs in the epigenetic regulation of pediatric cancers
|
Pathania, Anup S. |
|
|
83 |
C |
p. 227-241 |
artikel |
43 |
Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator
|
Li, Feng |
|
|
83 |
C |
p. 335-352 |
artikel |
44 |
Use of DNA methylation profiling in translational oncology
|
Ortiz-Barahona, Vanessa |
|
|
83 |
C |
p. 523-535 |
artikel |